STEM News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.

Press releases published on October 30, 2026

Oct. 30, 2026

Atsena Therapeutics Reports New Preclinical Data Demonstrating Robust MYO7A Expression and Favorable Safety for ATSN-301, a Laterally Spreading Dual AAV Vector-based Gene Therapy for Usher Syndrome Type 1B

Indeterminate GlobeNewswire

Oct. 30, 2026

Moleculin Completes Dosing Patients in Part A of Pivotal MIRACLE Trial; Comprehensive Data Readout on Track for Q1 2027

Indeterminate GlobeNewswire

Oct. 30, 2026

CDT Equity Welcomes U.S. Regulatory Development Supporting Expanded Access to Compounded Peptides

Indeterminate GlobeNewswire

Oct. 30, 2026

The Adult Stem Cell Assay Market is projected to expand at a 15.6% CAGR, reaching a value of $24.75 billion by 2030.

Indeterminate EIN Presswire

Oct. 30, 2026

The Adult Spinal Deformity Market Is Projected to Grow to $3.37 Billion by 2030 with a CAGR of 5.4%

Indeterminate EIN Presswire

Oct. 30, 2026

Werewolf Therapeutics Selected for Oral Presentation and to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 30, 2026

NETCLASS TECHNOLOGY INC Receives Outstanding Case Award for Its Multi-Agent AI Language Teaching System at 2026 Digital Lifelong Learning Conference

Indeterminate GlobeNewswire

Oct. 30, 2026

Zone Frontier Inc. Provides Shareholder Update on Minnesota Execution and Debt Financing Progress, Completed Strategic Transformation, Insider Share Purchases and Texas Project

Indeterminate GlobeNewswire

Oct. 30, 2026

Propanc Biopharma Advances Bioanalytical & Immunogenicity Assay Development for Phase 1b First-In-Human Study in up to 50 Advanced Cancer Patients

Indeterminate GlobeNewswire

Oct. 30, 2026

NurExone Demonstrates Consistent Anti-Inflammatory Activity Across Three Separate Batches of Exosomes

Indeterminate GlobeNewswire

Oct. 30, 2026

YOUEEFY Brings Building and Collecting Together Through Brick-Built Gun Models

Indeterminate GlobeNewswire

Oct. 30, 2026

Aer Therapeutics Announces Top-Line Results from its Phase 2a Proof-of-Concept Trial of Fexlamose in Chronic Obstructive Pulmonary Disease (“COPD”)

Indeterminate GlobeNewswire

Oct. 30, 2026

Vor Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Oct. 30, 2026

AURA DEER Introduces “Ways of Being” for Contemporary Tibetan Talisman Jewelry

Indeterminate GlobeNewswire

Oct. 30, 2026

SHARC Energy Announces Q3 2026 Financial Results and Record $10.1M Backlog

Indeterminate GlobeNewswire

Oct. 30, 2026

BigBattery Announces Commitments to Help Americans Own Their Power as LiFePO4 Goes Mainstream

Indeterminate GlobeNewswire

Oct. 30, 2026

Profound Medical and Cook Medical’s iMRI Division Partner to Expand U.S. TULSA-PRO® Sales Channels and Drive Recurring Revenue Growth

Indeterminate GlobeNewswire

Oct. 30, 2026

INDROTEK Discusses Relevance of OVIN Dual-Use Technology Findings to Its Robotics and Defense Activities

Indeterminate GlobeNewswire

Oct. 30, 2026

AI Visibility for Hotels and Resorts: No Company Holds More Than 3.1% of Mentions in AI Answers

Indeterminate GlobeNewswire

Oct. 30, 2026

Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study

Indeterminate GlobeNewswire